Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CATHNASDAQ:EEMANASDAQ:NXTGNASDAQ:PPH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATHGlobal X S&P 500 Catholic Values ETF$60.01-0.8%$61.98$49.45▼$63.77$790.93M1.0231,996 shs77,662 shsEEMAiShares MSCI Emerging Markets Asia ETF$65.79-0.7%$67.21$60.36▼$70.23$394.74M0.6943,459 shs10,783 shsNXTGFirst Trust Indxx NextG ETF$73.43-1.2%$77.91$64.46▼$81.22$359.81M0.8910,049 shs10,559 shsPPHVanEck Pharmaceutical ETF$85.14+0.3%$88.78$74.05▼$91.16$501.48M0.49124,373 shs72,869 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATHGlobal X S&P 500 Catholic Values ETF-0.13%-3.69%-3.51%+3.12%+19.24%EEMAiShares MSCI Emerging Markets Asia ETF+0.55%-4.18%-1.72%+5.38%+0.32%NXTGFirst Trust Indxx NextG ETF-0.11%-4.75%-4.84%-2.95%+8.94%PPHVanEck Pharmaceutical ETF-0.38%-2.22%-5.26%+0.58%+7.83%Secret Bull Market Starts in This Unusual Sector (Ad)"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCATHGlobal X S&P 500 Catholic Values ETFN/AN/AN/AN/AN/AN/AN/AN/AEEMAiShares MSCI Emerging Markets Asia ETFN/AN/AN/AN/AN/AN/AN/AN/ANXTGFirst Trust Indxx NextG ETFN/AN/AN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCATHGlobal X S&P 500 Catholic Values ETF0.00N/A$68.4013.98% UpsideEEMAiShares MSCI Emerging Markets Asia ETF0.00N/A$104.0758.19% UpsideNXTGFirst Trust Indxx NextG ETF0.00N/A$83.1813.28% UpsidePPHVanEck Pharmaceutical ETF0.00N/A$95.3712.02% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCATHGlobal X S&P 500 Catholic Values ETFN/AN/AN/AN/AN/AN/AEEMAiShares MSCI Emerging Markets Asia ETFN/AN/AN/AN/AN/AN/ANXTGFirst Trust Indxx NextG ETFN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCATHGlobal X S&P 500 Catholic Values ETFN/AN/A25.18∞N/AN/AN/AN/AN/AEEMAiShares MSCI Emerging Markets Asia ETFN/AN/A11.74∞N/AN/AN/AN/AN/ANXTGFirst Trust Indxx NextG ETFN/AN/A18.09∞N/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/A20.57∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCATHGlobal X S&P 500 Catholic Values ETF$0.671.12%N/AN/AN/AEEMAiShares MSCI Emerging Markets Asia ETF$1.482.25%N/AN/AN/ANXTGFirst Trust Indxx NextG ETF$1.642.23%N/AN/AN/APPHVanEck Pharmaceutical ETF$1.561.83%N/AN/AN/ALatest NXTG, PPH, CATH, and EEMA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2024PPHVanEck Pharmaceutical ETF$0.53284/1/20244/2/20244/5/20243/20/2024NXTGFirst Trust Indxx NextG ETFQuarterly$0.04403/21/20243/22/20243/28/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCATHGlobal X S&P 500 Catholic Values ETFN/AEEMAiShares MSCI Emerging Markets Asia ETFN/ANXTGFirst Trust Indxx NextG ETFN/APPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipCATHGlobal X S&P 500 Catholic Values ETFN/AEEMAiShares MSCI Emerging Markets Asia ETFN/ANXTGFirst Trust Indxx NextG ETFN/APPHVanEck Pharmaceutical ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCATHGlobal X S&P 500 Catholic Values ETF147,00013.18 millionN/AOptionableEEMAiShares MSCI Emerging Markets Asia ETF147,0006.00 millionN/ANot OptionableNXTGFirst Trust Indxx NextG ETF147,0004.90 millionN/AOptionablePPHVanEck Pharmaceutical ETF147,0005.89 millionN/AOptionableNXTG, PPH, CATH, and EEMA HeadlinesSourceHeadlineCanada’s updated guidance on ESG-related investment fund disclosuretheglobeandmail.com - April 18 at 10:38 AMJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focuszacks.com - April 17 at 11:00 AMVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328msn.com - April 3 at 8:35 AMVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328msn.com - April 1 at 2:26 PMShould You Invest in the VanEck Pharmaceutical ETF (PPH)?zacks.com - March 8 at 7:21 AMThe Top 3 ETFs to Buy in March 2024investorplace.com - March 7 at 1:43 PM11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yieldsmarkets.businessinsider.com - February 28 at 3:40 PMNavigate to Success With These 4 Pharma Stocks to Buystocknews.com - February 28 at 1:01 PMThe 3 Hottest Healthcare ETFs to Buy in 2024investorplace.com - February 26 at 2:12 PMPPH VanEck Pharmaceutical ETFseekingalpha.com - February 21 at 8:39 PMHealthcare dealmakers see increased M&A, valuations in 2024: KPMGmsn.com - February 20 at 7:16 AMPharma ETF (PPH) Hit a 52-Week Highzacks.com - February 19 at 9:50 AMBig Pharma earnings season in spotlight amid positive sentimentmsn.com - January 28 at 1:06 PM5 ETF Zones Scaling New Highs at the Start of 2024finance.yahoo.com - January 8 at 1:13 PMPfizer in 2024: What to expect?msn.com - December 29 at 1:39 PMGilead in 2024: What to expect?msn.com - December 28 at 1:41 PMETFs to buy and sell as the GLP-1 craze boomscnbc.com - December 6 at 9:53 AM10 Best Performing Healthcare ETFs in 2023uk.finance.yahoo.com - November 14 at 4:43 PMPharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your Portfoliomsn.com - November 6 at 1:27 PMPPH ETF Stock Price Historyinvesting.com - November 1 at 5:10 PMPPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfoliomsn.com - October 29 at 7:35 AM3 Resilient Pharma Stocks to Buy This Weekstocknews.com - October 26 at 9:05 PMOzempic craze drives big flows into pharmaceutical, Danish fundsmsn.com - October 25 at 12:42 PMEli Lilly, Novo among notable decliners in pharma weaknessseekingalpha.com - October 19 at 11:42 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsGlobal X S&P 500 Catholic Values ETFNASDAQ:CATHThe Global X S&P 500 Catholic Values ETF (CATH) is an exchange-traded fund that is based on the S&P 500 Catholic Values index. The fund tracks an index of US large-cap stocks selected from the S&P 500. The cap-weighted index omits companies from certain industries at odds with Catholic values. CATH was launched on Apr 18, 2016 and is managed by Global X.iShares MSCI Emerging Markets Asia ETFNASDAQ:EEMAThe iShares MSCI Emerging Markets Asia ETF (EEMA) is an exchange-traded fund that is based on the MSCI EM Asia Custom Capped index, a market-cap-weighted index of Asian emerging markets firms. EEMA was launched on Feb 8, 2012 and is managed by BlackRock.First Trust Indxx NextG ETFNASDAQ:NXTGThe First Trust IndXX NextG ETF (NXTG) is an exchange-traded fund that is based on the Indxx 5G & NextG Thematic index. The fund tracks a tiered-weighted index of global equities related to next generation digital cellular technologies. NXTG was launched on Feb 17, 2011 and is managed by First Trust.VanEck Pharmaceutical ETFNASDAQ:PPHThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.